{"id":"b1b7a2ef-267c-4571-a478-e999c75a5560","companyId":"ac5afad9-cfd5-4b66-aa18-4d3aacf16560","modelName":"Synchron Stentrode","slug":"synchron-stentrode","description":"The Synchron Stentrode is an endovascular brain-computer interface implant that does not require open-brain surgery. Implanted via the jugular vein, it detects brain signals to enable patients with severe paralysis (ALS) to communicate via thought. The Stentrode has been tested in COMMAND (US) and SWITCH (Australia) clinical trials with no serious device-related adverse events.","formFactor":"wearable","industryVertical":null,"environment":null,"maturityStage":"pilot","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://evtoday.com/news/synchrons-brain-computer-interface-evaluated-in-command-early-feasibility-study","title":"Synchron's BCI Evaluated in COMMAND Study","sourceName":"EV Today"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"CEO","value":"Tom Oxley (Founder, neurologist, Mount Sinai)"},{"label":"Total funding","value":"over $345M ($200M Series D 2024, $75M Series C 2022)"},{"label":"Product","value":"Stentrode (endovascular BCI implant, no open-brain surgery)"},{"label":"Clinical trials","value":"COMMAND (US, FDA-approved), SWITCH (Australia, 4 patients)"},{"label":"Safety","value":"No serious device-related adverse events in 6 patients"},{"label":"Target","value":"Patients with severe paralysis (ALS) to communicate via thought"}],"createdAt":"2026-07-06T06:57:53.960Z","updatedAt":"2026-07-08T20:02:15.945Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/synchron-stentrode","url":"https://registry.deploy.report/models/synchron-stentrode","name":"Synchron Stentrode","description":"The Synchron Stentrode is an endovascular brain-computer interface implant that does not require open-brain surgery. Implanted via the jugular vein, it detects brain signals to enable patients with severe paralysis (ALS) to communicate via thought. The Stentrode has been tested in COMMAND (US) and SWITCH (Australia) clinical trials with no serious device-related adverse events.","identifier":"b1b7a2ef-267c-4571-a478-e999c75a5560","category":"wearable","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"pilot","lifecycle_state":"active","architectural_position":{"cohort":"wearable","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}